Company: INDP
Filing Date: 2025-03-13
Form Type: POS AM
Source: 0001493152-25-010137
Chunk: 3

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-03-13
Form: POS AM
Chunk 3
---
 pursuant to this prospectus would be purchased by YA from time to time pursuant to the Purchase Agreement at a price equal to 97% of the lowest of the three daily volume weighted average prices, or VWAPs, during a pricing period as set forth in the Purchase Agreement and would be subject to certain limitations.

The selling stockholder may sell the shares of common stock included in this prospectus in a number of different ways and at varying prices. We provide more information about how the selling stockholder may sell the shares in the section entitled “Plan of Distribution.” The selling stockholder is an “underwriter” within the meaning of Section 2(a)(11) of the Securities Act of 1933, as amended, the Securities Act.

The selling stockholder will pay all brokerage fees and commissions and similar expenses in connection with the offer and sale of the shares by the selling stockholder pursuant to this prospectus. We will pay the expenses (except brokerage fees and commissions and similar expenses) incurred in registering under the Securities Act the offer and sale of the shares included in this prospectus by the selling stockholder. See “Plan of Distribution.”

Our common stock is listed on the Nasdaq Capital Market under the symbol “INDP”. On March 12, 2025, the last reported sale price of our common stock on the Nasdaq Capital Market was $0.84 per share.

Investing in our securities involves risks. See the section entitled “Risk Factors” included in into the prospectus.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is March , 2025</div>

<div align='center'>TABLE OF CONTENTS</div>

|                                                   | Page |
| ABOUT THIS PROSPECTUS                             |    1 |
| PROSPECTUS SUMMARY                                |    2 |
| THE OFFERING                                      |    6 |
| RISK FACTORS                                      |    7 |
| SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS |   10 |
| USE OF PROCEEDS                                   |   11 |
| DIVIDEND POLICY                                   |   12 |
| SELLING STOCKHOLDER                               |   13 |
| DESCRIPTION OF SECURITIES                         |   14 |
| PLAN OF DISTRIBUTION                              |   19 |
| LEGAL MATTERS                                     |